BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Alpha Biologics Sdn Bhd (ABSB) Release: UK Bioprocess Development Labs Open for Business


11/12/2010 11:04:12 AM

12th November 2010 New UK bioprocess development labs open for business Alpha Biologics, supplier of contract biomanufacturing services, today announced the opening of new process development laboratories at the Babraham Research Park in Cambridge, UK.

The company recently completed building an $18m manufacturing plant in Penang, Malaysia for the cGMP production of mammalian cell proteins. Now, in a further step, it has opened new UK labs designed to provide customers with services at earlier stages of the manufacturing process. These range from R&D and bioprocess development through to scale-up and optimisation of the biomanufacturing process.

The new laboratories are based within Babraham’s new, ultra-modern Maia biomedical complex. Michelle Peake, Alpha’s COO said: “Our key focus is on the manufacture of monoclonal antibodies and recombinant proteins - though clients may sometimes want whole cells, membrane fractions or other specified products. The UK labs have been designed to be flexible, so they can cope with any of these needs - they will suit researchers just starting to develop a biomanufacturing process all the way through to those preparing clinical trial materials".

"Once bioprocesses are optimised, they are transferred elsewhere for full-scale manufacture - that can either be at our own cGMP manufacturing plant, or other sites chosen by our clients”.

The new UK facility will be run by the company's Director of Process Development & Manufacturing, Mark Doran, who said: “We provide the full spectrum of biomanufacturing services including upstream process development, downstream protein purification and cell banking, too. If clients then wish to proceed to full-scale cGMP production, we can do that too.”

"The whole point is to create the best production process, shorten the product development cycle and increase productivity. Recently we were able to quadruple the yield of a particular product just by developing a better separation process, resulting in significant cost savings for our client".

Obtain further information from:

Mark Doran Tel: 01223 496070

Ian Robson Tel: 0191 487 5961

Alpha Biologics (www.alphabiologics.com) is an independent, privately owned company with R&D and production facilities in the UK and Malaysia. The two main operating bases are R&D and bioprocess development laboratories located on the Babraham Research Campus, Cambridge, at the heart of the UK's biotechnology industry and a 5,000 sq metre advanced cGMP biomanufacturing facility for mammalian cell proteins on the Penang Science Park, Malaysia.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES